论文部分内容阅读
目的探讨联合运用干扰素γ和沐舒坦雾化吸入治疗慢性支气管炎急性发作的临床疗效。方法慢支急性加重期病人96例,随机分为实验组(A)和对照组(B)两组。用氧启动雾化吸入治疗,A组联合运用干扰素γ和沐舒坦雾化液,B组运用沐舒坦雾化液。结果A组、B组的有效率为92.59%和69.05%,两组疗效差异有显著意义(P<0.0 1)。结论采用氧启动雾化联合运用干扰素γ和沐舒坦可以较好地改善慢支急性加重期症状。
Objective To investigate the clinical efficacy of combined use of interferon γ and mucosolvan inhalation in the treatment of acute exacerbation of chronic bronchitis. Methods Ninety-six patients with acute exacerbation of chronic bronchitis were randomly divided into experimental group (A) and control group (B). Start aerosol inhalation therapy with oxygen, A combined use of interferon gamma and mucosolvan aerosol, B group mucosolvan aerosol. Results The effective rates of group A and group B were 92.59% and 69.05%, respectively. There was significant difference between the two groups (P <0.01). Conclusion Oxygen-activated atomization combined with interferon-gamma and ambroxol can improve symptoms of acute exacerbation of chronic bronchitis.